No. 108, Meiliang Road
Mashan Binhu District
Full-time employees: 7,686
|Dr. Ge Li||Founder & Chairman||N/A||N/A||1967|
|Dr. Zhisheng Chen||CEO & Exec. Director||699.75k||N/A||1973|
|Dr. Weichang Zhou||Exec. VP, CTO & Exec. Director||374.6k||N/A||1964|
|Ms. Shaohua Lu-Wong||Co-CFO & Exec. VP||N/A||N/A||1969|
|Mr. Ming Tu||Co-CFO & Exec. VP||N/A||N/A||1968|
|Dr. Jijie Gu||Exec. VP & Chief Scientific Officer||N/A||N/A||1966|
|Ms. Eileen Wang||IR Sr. Director||N/A||N/A||N/A|
|Ms. Tang Shaogui M.B.A.||VP and Head of Global Corp. Communications & Public Affairs||N/A||N/A||N/A|
|Ms. Michelle M. Chen Ph.D.||VP & Head of Corp. Devel.||N/A||N/A||N/A|
|Mr. Angus Scott Marshall Turner||Sr. VP of Global Bus. Devel. & Alliance Management||N/A||N/A||1968|
WuXi Biologics (Cayman) Inc., an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sales of medicals; vaccine CDMO and related business; and material supplier activities. It has strategic partnerships with Almirall, S.A.; Vir Biotechnology, Inc.; Aravive, Inc.; Tubulis GmbH; Arcus Biosciences, Inc.; AC Immune SA; and AB2 Bio Ltd. The company was incorporated in 2014 and is headquartered in Wuxi, China. WuXi Biologics (Cayman) Inc. is a subsidiary of WuXi Biologics Holdings Limited.
WuXi Biologics (Cayman) Inc.’s ISS governance QualityScore as of 26 September 2021 is 2. The pillar scores are Audit: 4; Board: 8; Shareholder rights: 2; Compensation: 1.